This study aimed to construct a prognostic model for prognosis prediction and assess the response to adjuvant chemotherapy (ACT) of stage II gastric cancer
Additionally, the association between dose intensity of S-1 and survival rate was investigated. A total of 62 patients with stage II/III gastric cancer were retrospectively evaluated, each of whom had received a curative D2 gastrectomy and S-1 ACT. The relative performance (RP; administered/...
1 In China, the incidence of gastric cancer ranks second among all cancers.2 From 2012 to 2015, the 5-year survival rate of patients with gastric cancer in China was 35.1%,3 which was much lower than that in Japan (71.3%) during the same period.4 However, the National Cancer Center ...
Radical gastrectomy (RG) with lymph node (LN) dissection is a standard procedure for gastric cancer (GC). Patients with end-stage renal disease (ESRD) usually have high risk for any operative procedure. However, information for ESRD on RG for GC is limited.A total of 2,021 GC patients wh...
Methods: A retrospective study was performed in 300 consecutive patients with gastric cancer who had undergone curative resection with nodal yields of D2 or more from 1994 to 1997. The lymph node status was evaluated in two different extents. Group B included patients with whole harvested regional...
The patient did not present with recurrence at 2 years after surgery. Conclusions By actively administering preoperative chemotherapy, minimally invasive radical surgery with maximum preservation of the surrounding organs can be performed for locally far advanced-stage gastric cancer in older patients with...
In addition, many of the studies [4,6,7] included patients with stage I gastric cancer, and guidelines recommend that stage I gastric cancer should be treated only with radical surgery (without chemotherapy or radiotherapy), owing to its low recurrence rate and good disease-free survival [13,...
The 5-year survival rate in this population is 75% to 80%, and about 15% to 20% of these patients will eventually experience disease recurrence. Currently, there is no optimal strategy for clinical management of patients with stage II colon cancer. After surgical resection, adjuvant ...
In eastern countries, however, D2 lymphadenectomy has been adopted as standard clinical practice [8, 9]. Recent randomised controlled trials have shown that D2 radical surgery for gastric cancer can improve disease-specific survival in patients with advanced disease [10, 11]. The academic ...
The benefit of adjuvant therapy for patients with IB gastric cancer (GC) is a topic of debate. This study aimed to evaluate the benefit of adjuvant therapy